Noriki Fujimoto Selected Research

Noriki Fujimoto Research Topics

Disease

6	Neoplasms (Cancer) 09/2023 - 09/2014
4	Melanoma (Melanoma, Malignant) 01/2023 - 11/2021
4	Acne Vulgaris 09/2021 - 01/2011
3	COVID-19 05/2024 - 11/2022
3	Pemphigus (Pemphigus Vulgaris) 09/2023 - 07/2014
2	Infections 04/2024 - 11/2023
2	Exanthema (Rash) 04/2024 - 09/2021
2	Myositis (Idiopathic Inflammatory Myopathies) 11/2023 - 08/2016
2	Alopecia Areata 01/2023 - 09/2022
2	Bullous Pemphigoid (Pemphigoid) 01/2023 - 07/2013
2	Necrosis 01/2023 - 01/2020
2	Erythema Multiforme 01/2023 - 09/2021
2	Ulcer 01/2020 - 01/2018
2	Erythema 01/2020 - 01/2012
2	Inflammation (Inflammations) 01/2020 - 02/2014
2	Systemic Scleroderma (Systemic Sclerosis) 12/2018 - 01/2016
2	Lymphedema (Milroy Disease) 10/2016 - 02/2014
2	Skin Diseases (Skin Disease) 01/2012 - 01/2011
1	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 05/2024
1	Schnitzler Syndrome 04/2024
1	Vasculitis (Vasculitides) 04/2024
1	Xanthomatosis (Xanthoma) 10/2023
1	Extramammary Paget Disease (Paget Disease, Extramammary) 09/2023
1	Adenocarcinoma 09/2023
1	Colorectal Neoplasms (Colorectal Cancer) 09/2023
1	Disease Progression 01/2023
1	Pseudolymphoma 01/2023
1	Leukopenia 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Eosinophilic pustular folliculitis 11/2022
1	Hand-Foot Syndrome 09/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2021
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 04/2021
1	Seasonal Allergic Rhinitis (Hay Fever) 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Prurigo 12/2018
1	Granuloma Annulare 10/2018
1	Chronic Urticaria 08/2018
1	Fever (Fevers) 08/2018
1	Urticaria (Hives) 08/2018
1	Purpura Fulminans 06/2018
1	Protein C Deficiency 06/2018
1	Autoimmune Diseases (Autoimmune Disease) 01/2018
1	Pain (Aches) 01/2018

Drug/Important Bio-Agent (IBA)

4	AntibodiesIBA 09/2023 - 09/2014
3	Immunoglobulin A (IgA)IBA 04/2024 - 01/2018
3	Immunoglobulins (Immunoglobulin)IBA 04/2024 - 11/2012
3	AutoantigensIBA 11/2023 - 01/2018
3	CytokinesIBA 09/2023 - 01/2020
3	NivolumabIBA 01/2023 - 09/2021
3	Prednisolone (Predate)FDA LinkGeneric 08/2016 - 01/2011
3	Dapsone FDA Link 06/2013 - 01/2011
2	Messenger RNA (mRNA)IBA 05/2024 - 11/2022
2	AutoantibodiesIBA 11/2023 - 07/2014
2	SteroidsIBA 09/2022 - 01/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 08/2018
2	Minocycline (Cyclops)FDA LinkGeneric 10/2018 - 01/2017
1	Immunoglobulin G (IgG)IBA 04/2024
1	Immunoglobulin M (IgM)IBA 04/2024
1	osimertinibIBA 10/2023
1	DesmocollinsIBA 09/2023
1	nardilysinIBA 09/2023
1	Metalloendopeptidases (Metalloendopeptidase)IBA 09/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2023
1	Cysteine (L-Cysteine)FDA Link 01/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	Tramadol (K315)FDA LinkGeneric 01/2023
1	Arginine (L-Arginine)FDA Link 01/2023
1	Gemcitabine FDA Link 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	Diphosphates (Pyrophosphates)IBA 01/2023
1	Histidine (L-Histidine)FDA Link 01/2023
1	IpilimumabIBA 01/2023
1	dupilumabIBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	InterleukinsIBA 01/2023
1	2-mercaptopurineIBA 01/2023
1	130-nm albumin-bound paclitaxelIBA 01/2023
1	arginylarginine (Arg-Arg)IBA 01/2023
1	NucleosidesIBA 01/2023
1	VaccinesIBA 11/2022
1	RNA (Ribonucleic Acid)IBA 07/2022
1	Small Cytoplasmic RNAIBA 07/2022
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Sorafenib (BAY 43-9006)FDA Link 09/2021
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 04/2021
1	AllergensIBA 01/2020
1	fibrin fragment D (D-dimer)IBA 08/2018
1	Biomarkers (Surrogate Marker)IBA 08/2018
1	ThrombomodulinIBA 06/2018
1	Vancomycin FDA LinkGeneric 01/2018

Therapy/Procedure

5	Therapeutics 01/2023 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2023
2	Immunotherapy 11/2022 - 07/2022
2	Radiotherapy 11/2021 - 02/2014
1	Lasers (Laser) 11/2023
1	Aftercare (After-Treatment) 10/2023
1	Salvage Therapy 01/2023
1	Debridement 01/2020
1	Phototherapy (Light Therapy) 12/2018